The International Trade Commission published notices in the Feb. 12 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission published notices in the Feb. 11 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission published notices in the Feb. 7 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
President Donald Trump, speaking to reporters during a Feb. 7 press conference with Japan's Prime Minister, said that he would probably announce, either Monday or Tuesday, Feb. 10 or Feb. 11, "reciprocal tariffs where a country pays so much or charges us so much and we do the same, so very reciprocal because I think that's the only fair way to do it, that way nobody's hurt. They charge us, we charge them."
The International Trade Commission published notices in the Feb. 6 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission is issuing a limited exclusion order banning imports of medical admixture devices (ITC Inv. No. 337-TA-1362) from U.S. company Summit International Medical Technologies, Advcare Medical of Taiwan, and Dragon Heart of China, it said in a notice to be published Feb. 7. Additionally, the ITC issued cease and desist orders against Summit International but imposed no bond for covered articles imported or sold during the period of presidential review. The order concludes a Section 337 investigation the ITC launched in May 2023, based on allegations by West Pharmaceutical Services of Pennsylvania and West Pharma of Israel that the respondents are importing fluid transfer devices that have a trifurcated connector body with an integral vial adapter (see 2305100005) that copy and infringe its patented designs.
The International Trade Commission published notices in the Feb. 5 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission seeks comments by Feb. 14 on a Section 337 complaint alleging that imports of glass substrates infringe patents held by Corning Incorporated, it said in a notice to be published Feb. 6. According to the complaint, the complainant is seeking a limited exclusion order and cease and desist orders against LG, Hisense, HKC, and six other companies to bar from entry "certain glass substrates for liquid crystal displays, products containing the same, and methods for manufacturing the same" that violate the complainant's patents. The products are used in "display panels and electronic devices containing the same, including TVs, monitors, notebook and laptop computers, and tablets." This is the second complaint Corning has submitted in as many months (see 2412230044).
The International Trade Commission is beginning a Section 337 investigation on dryer wall exhaust vent assemblies (ITC Inv. No. 337-TA-1437) after receiving allegations filed by InOvate Acquisitions Company that Chinese company Xiamen Dirongte Trading Co., Ltd. is importing products that infringe its patents, the agency said in a notice to be published Feb. 6.
The following lawsuits were filed at the Court of International Trade during the week of Jan. 27 - Feb. 2: